Kano Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 11-20 Employees

Kano Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	$10,000,000

Key Contacts at Kano Therapeutics

Floris Engelhardt

Co-Founder & Ceo

John Vroom

Co-Founder

Scott Hamilton

Director Of Cmc

Greg Foley

Associate Director - Synthetic Biology

Company overview

Headquarters	Cambridge, Massachusetts, United States
Phone number	+16174859448
Website	kanotherapeutics.com
NAICS	541714
Keywords	Biotechnology, Gene Therapy, Crispr, Biological Engineering, Dna Therapeutics
Founded	2021
Employees	11-20
Socials

Kano Therapeutics Email Formats

Kano Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@kanotherapeutics.com), used 60% of the time.

Format	Example	Percentage
{first initial}	j@kanotherapeutics.com	60%
{first name}	john@kanotherapeutics.com	40%

About Kano Therapeutics

Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Senior

Entry

Director

Employees by Department

Kano Therapeutics has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Kano Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-20	1	$5,000,000
2024-09-12	3	$5,000,000

Funding Insights

$10,000,000

Total funding amount

$5,000,000

Most recent funding amount

Number of funding rounds

Kano Therapeutics Tech Stack

Discover the technologies and tools that power Kano Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

Bluehost

Hosting

WordPress

Blogs

LottieFiles

Miscellaneous

PWA

Miscellaneous

lit-element

JavaScript libraries

MySQL

Databases

lit-html

JavaScript libraries

Frequently asked questions

Kano Therapeutics is located in Cambridge, Massachusetts, US.

You can reach Kano Therapeutics at +16174859448.

Kano Therapeutics generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

Kano Therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kano Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Kano Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Kano Therapeutics has raised a total of $10,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kano Therapeutics

Floris Engelhardt

Co-Founder & Ceo

John Vroom

Co-Founder

Scott Hamilton

Director Of Cmc

Greg Foley

Associate Director - Synthetic Biology

4.8

40,000 users